Pediatric gastritis and its impact on hematologic parameters

Maria Oana Săsăran1, Lorena Elena Meliţ2, Simona Mocan3

  • 1Department of Pediatric Cardiology, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology from Târgu Mureş.

Medicine
|September 3, 2020
PubMed

Insights

Pediatric gastritis, whether H. pylori-induced or not, does not significantly alter platelet counts or common inflammatory ratios. However, increased lymphocyte counts may indicate non-H. pylori gastritis, while severe cases can lower hemoglobin and hematocrit.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Immunology

Background:

  • Non-invasive biomarkers like neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) show potential for predicting inflammation.
  • Helicobacter pylori (H. pylori) infection is linked to immune thrombocytopenia in both pediatric and adult patients.
  • The impact of pediatric gastritis on hematological parameters, including erythrocytes and thrombocytes, requires further investigation.

Purpose of the Study:

  • To evaluate the effect of H. pylori-induced and non-H. pylori pediatric gastritis on erythrocytes, thrombocytes, mean platelet volume, NLR, and PLR.
  • To determine if specific hematological parameters can differentiate between H. pylori and non-H. pylori gastritis in children.
  • To assess the relationship between gastritis severity and hematological parameter changes in pediatric patients.

Main Methods:

  • A prospective, case-control study involving 151 pediatric patients (1-17 years) with chronic dyspeptic symptoms.
  • Upper digestive endoscopy with gastric biopsies and complete blood count analysis.
  • Comparison between a control group (normal histology), H. pylori-induced gastritis group, and non-H. pylori-induced gastritis group.

Main Results:

  • No significant differences in platelets, mean platelet volume, NLR, or PLR were observed between gastritis groups and the control group.
  • Significantly higher lymphocyte values were associated with non-H. pylori-induced gastritis (P < .01).
  • Severe gastritis correlated with a significant decrease in hemoglobin (Hb) and hematocrit (Htc) levels.

Conclusions:

  • Pediatric gastritis, irrespective of H. pylori status, does not significantly affect platelet counts, mean platelet volume, PLR, or NLR.
  • An elevated lymphocyte count may serve as a potential indicator for non-H. pylori pediatric gastritis.
  • Severe gastritis in children can lead to a notable reduction in Hb and Htc levels.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
172
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
940
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.8K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
103